Literature DB >> 33719038

Evidence of robust memory T-cell responses in patients with chronic myeloproliferative neoplasms following infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).

Patrick Harrington1,2, Claire N Harrison1,2, Richard Dillon1,2, Deepti H Radia1, Katayoun Rezvani3, Kavita Raj1, Claire Woodley1, Natalia Curto-Garcia1, Jennifer O'Sullivan1, Jamie Saunders1, Shahram Kordasti1,2, Sahra Ali1, Hugues de Lavallade1,2,4, Donal P McLornan1,2.   

Abstract

Entities:  

Keywords:  CML; COVID-19; T cell; immunity; myeloproliferative neoplasm

Mesh：

Substances：

Year:  2021        PMID： 33719038     DOI： 10.1111/bjh.17402

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  5 in total

Review 1.  JAK inhibitors and COVID-19.

Authors:  Gabriel Levy; Paola Guglielmelli; Peter Langmuir; Stefan N Constantinescu
Journal:  J Immunother Cancer       Date:  2022-04       Impact factor: 12.469

2.  Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) induces neutralising antibody and polyfunctional T-cell responses in patients with chronic myeloid leukaemia.

Authors:  Patrick Harrington; Katie J Doores; Deepti Radia; Amy O'Reilly; Ho Pui Jeff Lam; Jeffrey Seow; Carl Graham; Thomas Lechmere; Donal McLornan; Richard Dillon; Yogita Shanmugharaj; Andreas Espehana; Claire Woodley; Jamie Saunders; Natalia Curto-Garcia; Jennifer O'Sullivan; Kavita Raj; Shahram Kordasti; Michael H Malim; Claire Harrison; Hugues de Lavallade
Journal:  Br J Haematol       Date:  2021-06-03       Impact factor: 8.615

3.  Large Scale Internet-based Survey of Patients With a Myeloproliferative Neoplasm: Opinions and Experiences Regarding SARS-CoV-2 (COVID-19) Vaccination Strategies in 2021.

Authors:  Jamie Saunders; Natalia Curto-Garcia; Priya Sriskandarajah; Jennifer O'Sullivan; Claire Woodley; Susan Asirvatham; Marion Campbell-Drew; Jonathan Mathias; Tim Ellis; Nona Baker; Deepti H Radia; Sahra Ali; Shahram Kordasti; Patrick Harrington; Hugues de Lavallade; Donal P McLornan; Claire N Harrison
Journal:  Hemasphere       Date:  2021-06-23

4.  T cell-mediated response to SARS-CoV-2 in liver transplant recipients with prior COVID-19.

Authors:  Mario Fernández-Ruiz; Beatriz Olea; Patricia Almendro-Vázquez; Estela Giménez; Alberto Marcacuzco; Rafael San Juan; Iago Justo; Jorge Calvo-Pulido; Álvaro García-Sesma; Alejandro Manrique; Oscar Caso; Félix Cambra; Paloma Talayero; Francisco López-Medrano; María José Remigia; Tamara Ruiz-Merlo; Patricia Parra; Estela Paz-Artal; Carlos Jiménez; Carmelo Loinaz; David Navarro; Rocío Laguna-Goya; José M Aguado
Journal:  Am J Transplant       Date:  2021-06-25       Impact factor: 9.369

5.  Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus.

Authors:  C Buske; M Dreyling; A Alvarez-Larrán; J Apperley; L Arcaini; C Besson; L Bullinger; P Corradini; M Giovanni Della Porta; M Dimopoulos; S D'Sa; H T Eich; R Foà; P Ghia; M G da Silva; J Gribben; R Hajek; C Harrison; M Heuser; B Kiesewetter; J J Kiladjian; N Kröger; P Moreau; J R Passweg; F Peyvandi; D Rea; J-M Ribera; T Robak; J F San-Miguel; V Santini; G Sanz; P Sonneveld; M von Lilienfeld-Toal; C Wendtner; G Pentheroudakis; F Passamonti
Journal:  ESMO Open       Date:  2022-01-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.